Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Astrid G S van Halteren"'
Autor:
Wilmar Ghuijs, Paul G. Kemps, Marta E. Capala, Robert M. Verdijk, Astrid G. S. van Halteren, Robert J. P. van der Wal, Jan A. M. van Laar
Publikováno v:
Radiation Oncology, Vol 17, Iss 1, Pp 1-6 (2022)
Abstract Background Langerhans cell histiocytosis (LCH) is a rare haematological neoplasm characterized by the accumulation of CD1a+, CD207/Langerin+ histiocytes within inflammatory lesions. LCH can involve any organ, but osteolytic bone lesions are
Externí odkaz:
https://doaj.org/article/2a1e48c1278d484c9f48c5c4430ffc82
Autor:
Astrid G. S. van Halteren, Jessica S. Suwandi, Sander Tuit, Jelske Borst, Sandra Laban, Roula Tsonaka, Ada Struijk, Anna-Sophia Wiekmeijer, Melissa van Pel, Bart O. Roep, Jaap Jan Zwaginga, Arjan C. Lankester, Koen Schepers, Maarten J. D. van Tol, Willem E. Fibbe
Publikováno v:
Blood. 141(11):1277-1292
Acute graft-versus-host disease (aGVHD) is an immune cell‒driven, potentially lethal complication of allogeneic hematopoietic stem cell transplantation affecting diverse organs, including the skin, liver, and gastrointestinal (GI) tract. We applied
Autor:
Paul G. Kemps, Timo C. E. Zondag, Helga B. Arnardóttir, Nienke Solleveld-Westerink, Jelske Borst, Eline C. Steenwijk, Demi van Egmond, Joost F. Swennenhuis, Ellen Stelloo, Irene Trambusti, Robert M. Verdijk, Carel J. M. van Noesel, Arjen H. G. Cleven, Marijn A. Scheijde-Vermeulen, Marco J. Koudijs, Lenka Krsková, Cynthia Hawkins, R. Maarten Egeler, Jesper Brok, Tatiana von Bahr Greenwood, Karel Svojgr, Auke Beishuizen, Jan A. M. van Laar, Ulrike Pötschger, Caroline Hutter, Elena Sieni, Milen Minkov, Oussama Abla, Tom van Wezel, Cor van den Bos, Astrid G. S. van Halteren
Publikováno v:
Blood advances, 7(4), 664-679. American Society of Hematology
Langerhans cell histiocytosis (LCH) is a rare neoplastic disorder caused by somatic genetic alterations in hematopoietic precursor cells differentiating into CD1a+/CD207+ histiocytes. LCH clinical manifestation is highly heterogeneous. BRAF and MAP2K
Autor:
Paul G. Kemps, Timo C. Zondag, Eline C. Steenwijk, Quirine Andriessen, Jelske Borst, Sandra Vloemans, Dave L. Roelen, Lenard M. Voortman, Robert M. Verdijk, Carel J. M. van Noesel, Arjen H. G. Cleven, Cynthia Hawkins, Veronica Lang, Arnoud H. de Ru, George M. C. Janssen, Geert W. Haasnoot, Kees L. M. C. Franken, Ronald van Eijk, Nienke Solleveld-Westerink, Tom van Wezel, R. Maarten Egeler, Auke Beishuizen, Jan A. M. van Laar, Oussama Abla, Cor van den Bos, Peter A. van Veelen, Astrid G. S. van Halteren
Publikováno v:
Frontiers in Immunology, Vol 10 (2020)
Langerhans Cell Histiocytosis (LCH) is a neoplastic disorder of hematopoietic origin characterized by inflammatory lesions containing clonal histiocytes (LCH-cells) intermixed with various immune cells, including T cells. In 50–60% of LCH-patients,
Externí odkaz:
https://doaj.org/article/e72482c223694d18a86b7155b95eb24c
Autor:
Lisa V. E. Oostenbrink, Cornelia M. Jol-van der Zijde, Katrine Kielsen, Anja M. Jansen-Hoogendijk, Marianne Ifversen, Klaus G. Müller, Arjan C. Lankester, Astrid G. S. van Halteren, Robbert G. M. Bredius, Marco W. Schilham, Maarten J. D. van Tol
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Anti-thymocyte globulin (ATG) is a lymphocyte depleting agent applied in hematopoietic stem cell transplantation (HSCT) to prevent rejection and Graft-vs.-Host Disease (GvHD). In this study, we compared two rabbit ATG products, ATG-Genzyme (ATG-GENZ)
Externí odkaz:
https://doaj.org/article/8044e135e7df45b3a36d392be8be61d7
Autor:
Anja M. Jansen-Hoogendijk, Astrid G. S. van Halteren, Robbert G. M. Bredius, Maarten J. D. van Tol, Alexander B. Mohseny, Lisa V E Oostenbrink, Emma S. Pool, Arjan C. Lankester, Cornelia M. Jol-van der Zijde, Frans J. Smiers, Carly Vervat, Marco W. Schilham
Publikováno v:
Bone Marrow Transplantation. SPRINGERNATURE
Bone Marrow Transplantation
Bone Marrow Transplantation
The use of HLA-mismatched (un)related donors is historically associated with a higher incidence of transplant-related complications and mortality. However, the use of such donors may overcome the limited availability of HLA-matched donors for patient
Autor:
Maarten J. D. van Tol, Anja M. Jansen-Hoogendijk, Cornelia M. Jol-van der Zijde, Robbert G. M. Bredius, Astrid G. S. van Halteren, Emma S. Pool, Dirk Jan A.R. Moes, Alex B. Mohseny, Lisa V E Oostenbrink, Marco W. Schilham, Arjan C. Lankester, Frans J. Smiers
Publikováno v:
Hematology/Oncology and Stem Cell Therapy, Vol 13, Iss 2, Pp 61-65 (2020)
Antithymocyte globulin (ATG) is a widely accepted part of the conditioning regimen applied in the setting of hematopoietic stem cell transplantation (HSCT) to prevent graft rejection and graft-versus-host disease. Although weight-based dosing of ATG
Autor:
Oussama Abla, Stephen Peeke, Irem Eldem, Marianne D. van de Wetering, Jennifer Picarsic, Kseniya Petrova-Drus, Robert B. Lorsbach, Jan A M van Laar, Paul Geraeds Kemps, Sylvie Fraitag, Sébastien Héritier, Kristian T. Schafernak, Amy A. Swanson, Eli L. Diamond, Raf Sciot, Karen Ernestus, Mariko Suchi, Nabeel R. Yaseen, Sanda Alexandrescu, Laura Sophia Hiemcke-Jiwa, Matthew Collin, Ingrid S Tam, Sabrina Rossi, Benjamin H. Durham, F J Sherida H Woei-A-Jin, James A. Whitlock, Brianna Empringham, Laura Munoz-Arcos, Falko Fend, Olga Gryniewicz-Kwiatkowska, Majid Madni, Verena Wiegering, Kerry Turner, Dina El Demellawy, Gianpiero Tamburrini, Aditya Raghunathan, Lucas R. Massoth, Carel J. M. van Noesel, Robert Möhle, Cor van den Bos, Jacinthe Bonneau-Lagacherie, Somak Roy, Pasquale M Barbaro, Andreas Beilken, Stefania Gaspari, Jean-François Emile, David D. Grier, Claire Lamaison, Kee Kiat Yeo, Jean Donadieu, Jon M Brandt, Laure Farnault, Friedrich Feuerhake, Marie-Laure Jullie, Uta Flucke, Pancras C.W. Hogendoorn, Astrid G. S. van Halteren, Antje Bornemann, Bryan A. Sisk, Tina Méry, Joanna Weinstein, Ashish R Kumar, Robert M. Verdijk, V. Baykov, Alysa A Poulin, Mandy M Atkinson, VG Potapenko, Vaish Sridhar, Julien Haroche, Zofia Hélias-Rodzewicz, Shipra Garg, Susan Picton, Michael M. Henry, Jackie Allotey, Daniel Leino, Nishant Tiwari, Martin Ebinger, Jason L Hornick, Bożenna Dembowska-Bagińska, Marco Gessi, Dmitry A Evseev
Publikováno v:
Blood
Blood, 139(2), 256-280. AMER SOC HEMATOLOGY
Blood, 139(2), 256-280. American Society of Hematology
Blood, 2022, 139 (2), pp.256-280. ⟨10.1182/blood.2021013338⟩
Blood, 139, 256-280
Blood, 139, 2, pp. 256-280
Blood, 139(2), 256-280. AMER SOC HEMATOLOGY
Blood, 139(2), 256-280. American Society of Hematology
Blood, 2022, 139 (2), pp.256-280. ⟨10.1182/blood.2021013338⟩
Blood, 139, 256-280
Blood, 139, 2, pp. 256-280
Contains fulltext : 249882.pdf (Publisher’s version ) (Closed access) ALK-positive histiocytosis is a rare subtype of histiocytic neoplasm first described in 2008 in 3 infants with multisystemic disease involving the liver and hematopoietic system.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fe217ff12356ba76b44d2d33c6d436e
https://hdl.handle.net/1887/3563700
https://hdl.handle.net/1887/3563700
Autor:
Astrid G. S. van Halteren, Arjan C. Lankester, Marianne Ifversen, Lisa V E Oostenbrink, Robbert G. M. Bredius, Cornelia M. Jol-van der Zijde, Erik G J von Asmuth, Marco W. Schilham, Maarten J. D. van Tol, Anja M. Jansen-Hoogendijk, Klaus Müller, Katrine Kielsen, Carsten Heilmann, Monique M. van Ostaijen-ten Dam
Publikováno v:
Journal of Immunology, 206(12), 2828-2838. AMER ASSOC IMMUNOLOGISTS
Differentially and functionally distinct T cell subsets are involved in the development of complications after allogeneic hematopoietic stem cell transplantation (HSCT), but little is known about factors regulating their recovery after HSCT. In this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e17915f30c6f1c1c4c11e850ad35b8d1
https://hdl.handle.net/1887/3264386
https://hdl.handle.net/1887/3264386
Autor:
Miranda P Dierselhuis, Ewa Jankowska-Gan, Els Blokland, Jos Pool, William J Burlingham, Astrid G S van Halteren, Els Goulmy
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e91274 (2014)
Sex difference is an established risk factor for hematopoietic stem cell transplantation (HSCT)-related complications like graft versus host disease (GVHD). CD8pos cytotoxic T cells specific for Y chromosome-encoded minor Histocompatibility antigens
Externí odkaz:
https://doaj.org/article/014d146200644273897296edba74785e